Literature DB >> 33855975

The BBSome: a nexus controlling energy metabolism in the brain.

Sandra Blaess1, Dagmar Wachten2.   

Abstract

Bardet-Biedl syndrome (BBS) is a syndromic ciliopathy that has obesity as a cardinal feature. BBS is caused by mutations in BBS genes. BBS proteins control primary cilia function, and BBS mutations therefore lead to dysfunctional primary cilia. Obesity in patients with BBS is mainly caused by hyperphagia due to dysregulated neuronal function in the brain, in particular in the hypothalamus. However, the mechanism by which mutations in BBS genes result in dysfunction in hypothalamic neurons is not well understood. In this issue of the JCI, Wang et al. used BBS and non-BBS patient-derived induced pluripotent stem cells to generate neurons and hypothalamic neurons. Using this human model system, the authors demonstrated that mutations in BBS genes affected primary cilia function, neuronal morphology, and signaling pathways regulating the function of hypothalamic neurons, which control energy homeostasis. This study provides important insights into the mechanisms of BBS-induced obesity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33855975      PMCID: PMC8262486          DOI: 10.1172/JCI148903

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Bardet-Biedl syndrome.

Authors:  Elizabeth Forsythe; Philip L Beales
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

2.  The BBSome in POMC and AgRP Neurons Is Necessary for Body Weight Regulation and Sorting of Metabolic Receptors.

Authors:  Deng-Fu Guo; Zhihong Lin; Yuanming Wu; Charles Searby; Daniel R Thedens; George B Richerson; Yuriy M Usachev; Justin L Grobe; Val C Sheffield; Kamal Rahmouni
Journal:  Diabetes       Date:  2019-05-24       Impact factor: 9.461

3.  Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome.

Authors:  Gayle B Collin; Jan D Marshall; Akihiro Ikeda; W Venus So; Isabelle Russell-Eggitt; Pietro Maffei; Sebastian Beck; Cornelius F Boerkoel; Nicola Sicolo; Mitchell Martin; Patsy M Nishina; Jürgen K Naggert
Journal:  Nat Genet       Date:  2002-04-08       Impact factor: 38.330

4.  BBS7 is required for BBSome formation and its absence in mice results in Bardet-Biedl syndrome phenotypes and selective abnormalities in membrane protein trafficking.

Authors:  Qihong Zhang; Darryl Nishimura; Tim Vogel; Jianqiang Shao; Ruth Swiderski; Terry Yin; Charles Searby; Calvin S Carter; Gunhee Kim; Kevin Bugge; Edwin M Stone; Val C Sheffield
Journal:  J Cell Sci       Date:  2013-04-09       Impact factor: 5.285

Review 5.  Establishing and regulating the composition of cilia for signal transduction.

Authors:  Maxence V Nachury; David U Mick
Journal:  Nat Rev Mol Cell Biol       Date:  2019-07       Impact factor: 94.444

6.  Brain tissue- and region-specific abnormalities on volumetric MRI scans in 21 patients with Bardet-Biedl syndrome (BBS).

Authors:  Kim M Keppler-Noreuil; Catherine Blumhorst; Julie C Sapp; Danielle Brinckman; Jennifer Johnston; Peggy C Nopoulos; Leslie G Biesecker
Journal:  BMC Med Genet       Date:  2011-07-27       Impact factor: 2.103

7.  Regulation of Insulin Receptor Trafficking by Bardet Biedl Syndrome Proteins.

Authors:  Rachel D Starks; Andreas M Beyer; Deng Fu Guo; Lauren Boland; Qihong Zhang; Val C Sheffield; Kamal Rahmouni
Journal:  PLoS Genet       Date:  2015-06-23       Impact factor: 5.917

Review 8.  From the cytoplasm into the cilium: bon voyage.

Authors:  Jarema Malicki; Tomer Avidor-Reiss
Journal:  Organogenesis       Date:  2014-05-02       Impact factor: 2.500

Review 9.  Cilia signaling and obesity.

Authors:  Staci E Engle; Ruchi Bansal; Patrick J Antonellis; Nicolas F Berbari
Journal:  Semin Cell Dev Biol       Date:  2020-05-25       Impact factor: 7.727

10.  Disruption of type 3 adenylyl cyclase expression in the hypothalamus leads to obesity.

Authors:  Hong Cao; Xuanmao Chen; Yimei Yang; Daniel R Storm
Journal:  Integr Obes Diabetes       Date:  2016-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.